Kolexia
Deconinck Eric Hématologie
Deconinck Eric
Hématologie
Hôpital Jean-Minjoz
Besançon, France
307 Activités
317 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Lymphomes Maladie du greffon contre l'hôte Tumeurs hématologiques Maladie de Hodgkin Myélome multiple Leucémie-lymphome lymphoblastique à précurseurs B et T

Collaborateurs

Voir plus
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France
Blaise Didier
Blaise Didier
Centre Paoli-Calmettes, Marseille, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Socie Gerard
Socie Gerard
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
STEMLINE THERAPEUTICS SWITZERLAND GMBH
13 collaboration(s)
Dernière en 2023
Novartis
9 collaboration(s)
Dernière en 2023
Janssen
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
RESOLVE AML001: An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Essai Clinique (Advesya SAS)   20 février 2024
HLA Mismatching and Transplant Outcome in the Ptcy Era: A Comprehensive Study By the EBMT Cellular Therapy and Immunobiology Working Party
Abstracts from the 2024 Tandem Meetings of ASTCT and CIBMTR, February 21-24, 2024, San Antonio, Texas, USA   01 février 2024
Kidney transplantation after allogeneic Hematopoietic cell transplantation
Kidney international reports   30 janvier 2024
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica   11 janvier 2024
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Clinical lymphoma, myeloma & leukemia   20 décembre 2023
Durable Outcomes with Manageable Safety Leading to Prolonged Survival with Tagraxofusp for Treatment-Naive Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: Updated Results from a European Named Patient Program
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party
65th ASH Annual Meeting Abstracts   02 novembre 2023
Analysis of Tagraxofusp Activity in AML-Pdc As a Single Agent and in Combination with BCL2 Inhibitors
65th ASH Annual Meeting Abstracts   02 novembre 2023